Longdom Conferences

Speaker

July 22, 2020    London, UK

Webinar on Microbiology and Future Applications

Oleg Reva
Room1

Oleg Reva

southafrica

Title: Mechanisms of induction of antibiotic resistance reversion through epigenetic modification of bacterial DNA caused by iodine-containing nano-molecular complexes

Abstract:

Wide distribution of antibiotic resistant infections is a global challenge to public health. Pre-treatment of drug resistant bacteria with newly developed iodine-containing complex FS-1 makes them sensitive to regular antibiotics. This phenomenon was demonstrated in vitro and in clinical trials on multidrug resistant Mycobacterium tuberculosis, Staphylococcus aureus, Escherichia coli and Acinetobacter baumannii. Possible mechanisms of drug resistance reversion were studied experimentally and by deep DNA and RNA sequencing using PacBio and IonTorrent technologies on two reference strains – MRSA S. aureus ATCC BAA-39TM and ESBL E. coli ATCC BAA-196TM. In both cases, a stable reversion to antibiotic sensitive phenotype was achieved associated with alterations in gene expression patterns reflecting a general oxidative stress and deregulation of drug resistance mechanisms. The latter effect correlated with observed abnormalities in epigenetic modifications of bacterial chromosomes compared to control conditions. Epigenetic patterning of sequenced chromosomes was performed using the SMRT base-call kinetics analysis in PacBio reads. The most dramatic changes were observed in the level of methylation of chromosomal architecture imparting sequences (AIMS) orchestrating the DNA replication and reparation in bacteria. Moreover, a significant increase in number of modified, putatively oxidized nucleotides was observed. It was shown with a statistical reliability that the abnormal modifications of nucleotides within bodies of genes encoding for ncRNA in S. aureus do correlate with the observed alterations in the expression of these top level regulatory elements that deregulate the general gene expression in the affected bacteria. Discovered mechanisms of drug resistance reversion provide us with new approaches to overcome drug resistance problem.

Keywords: drug resistance, epigenetics, PacBio sequencing, RNA sequencing, FS-1

Useful Links

News

Coronavirus disease (COVID-19)

2020-03-12

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.

World experts and funders set priorities for COVID-19 research

2020-03-12

Leading health experts from around the world have been meeting at the World Health Organization’s Geneva headquarters to assess the current level of knowledge about the new COVID-19 disease, identify gaps and work together to accelerate and fund priority research needed to help stop this outbreak and prepare for any future outbreaks. The 2-day forum was convened in line with the WHO R&D Blueprint – a strategy for developing drugs and vaccines before epidemics, and accelerating research and development while they are occurring. “This outbreak is a test of solidarity -- political, financial and scientific. We need to come together to fight a common enemy that does not respect borders, ensure that we have the resources necessary to bring this outbreak to an end and bring our best science to the forefront to find shared answers to shared problems. Research is an integral part of the outbreak response,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “I appreciate the positive response of the research community to join us at short notice and come up with concrete plans and commitment to work together.” The meeting, hosted in collaboration with GloPID-R (the Global Research Collaboration for Infectious Disease Preparedness) brought together major research funders and over 300 scientists and researchers from a large variety of disciplines. They discussed all aspects of the outbreak and ways to control it including: the natural history of the virus, its transmission and diagnosis; animal and environmental research on the origin of the virus, including management measures at the human-animal interface; epidemiological studies; clinical characterization and management of disease caused by the virus; infection prevention and control, including best ways to protect health care workers; research and development for candidate therapeutics and vaccines; ethical considerations for research; and integration of social sciences into the outbreak response.

Newsletter

© 2024 All Rights Reserved by Longdom